In a May 2025 decision, the U.S. Supreme Court allows presidential replacement of independent agency leaders before their constitutional challenges are resolved.
The Federal Circuit revived UC Berkeley’s claim to key CRISPR gene editing patents, directing the USPTO to reconsider if its findings predate Broad Institute’s.
FDA declined to appeal a court ruling invalidating its 2024 LDT rule, concluding its push to expand regulatory control over lab-developed tests.
In Sigray v. Zeiss, the Federal Circuit reversed a PTAB ruling, holding that an implicit claim construction error led to wrongly upholding X-ray imaging patent claims.
